Menu button
ASMBS Logo

After 30 Years — New Guidelines For Weight-Loss Surgery

Posted 10/21/2022

For Immediate Release October 21, 2022

CONTACT: Roger Kissin rkissin@compartnersny.com

Medical Groups Replace Outdated Consensus Statement that Overly Restricts Access to Modern-Day Weight-Loss Surgery

NEWBERRY, FL – Oct. 21, 2022 – Two of the world’s leading authorities on bariatric and metabolic surgery have issued new evidence-based clinical guidelines that among a slew of recommendations expand patient eligibility for weight-loss surgery and endorse metabolic surgery for patients with type 2 diabetes beginning at a…

Read More

New Study Shows Significant Drop in Liver and Heart Disease in Patients with Fatty Liver After Weight-Loss Surgery

Posted 11/12/2021

ASMBS Statement on Cleveland Clinic Study

Newswise — NEWBERRY, FL – Nov. 11, 2021– A new Cleveland Clinic study shows that patients with obesity and advanced fatty liver disease who had bariatric surgery (weight-loss surgery) significantly lowered their risk for severe liver disease and serious cardiovascular disease, including heart attack and stroke, compared to patients who did not have the surgery. The study was published online today in JAMA.

Researchers found bariatric surgery was associated…

Read More

Bariatric Surgery Slashes Spending on Diabetes and Hypertension Medications

Posted 6/20/2019

Patients with severe obesity who get weight-loss surgery cut their spending on diabetes medications by nearly 65 percent and spending on high blood pressure medications by more than a third three to six months after the operation, according to new research from Rush Medical College in Chicago presented here at an American Society for Metabolic and Bariatric Surgery (ASMBS) national clinical symposium on obesity prevention, treatment and research.

Read More

Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now

×